Join our Mailing List

Zoomedia is a leading communications agency dedicated to increasing our clients' value through insightful and imaginative creative programs for the life sciences industry.

For questions or comments about this site, please contact info@hypeandhope.com.

Hype & Hope is an information and education channel focused on key issues within the life sciences. We provide news, events, editorial, stock indices, video, and image libraries on issues including stem cells, personalized medicine, and clinical trials.

The content we provide is designed to inform the debate around emerging issues in life sciences and how these issues impact the future of medicine. The service is provided free of charge. Advertising opportunities are available on the site and we do accept editorial submissions. We welcome your input to help us continue to inform and educate the media, industry, and public-at-large. Contact us directly, or sign-up to receive the Hype & Hope eNewsletter. If you would like to join our invitation-only blog please register here.

Stem Cells	Personalized Medicine
Editorial Staying the Course By: Michael J. Werner I never wanted Zach Hall’s job. Now it appears he doesn’t want it anymore either. The former View all Editorials News Updates on Stem Cell Research and Multiple Sclerosis Multiple Sclerosis (MS) is an autoimmune condition wherein the body’s immune system recognizes nerve fibres as the en View all News	Editorial A Bottle-Nosed Approach to Personalized Medicine By: Barbara Lavery, CEO Zoomedia Six years ago I attended a biotech conference in San Francisco. One of the panels that View all Editorials News MIT researcher offers hope for syndrome that causes retardation, autism Blocking a key brain chemical can reverse many of the symptoms of Fragile X Syndrome -- an inherited form of mental reta View all News

Stem Cells

Personalized Medicine

Editorial

Staying the Course

By: Michael J. Werner I never wanted Zach Hall’s job. Now it appears he doesn’t want it anymore either. The former

View all Editorials

News

Updates on Stem Cell Research and Multiple Sclerosis

Multiple Sclerosis (MS) is an autoimmune condition wherein the body’s immune system recognizes nerve fibres as the en

View all News

Editorial

A Bottle-Nosed Approach to Personalized Medicine

By: Barbara Lavery, CEO Zoomedia Six years ago I attended a biotech conference in San Francisco. One of the panels that

View all Editorials

News

MIT researcher offers hope for syndrome that causes retardation, autism

Blocking a key brain chemical can reverse many of the symptoms of Fragile X Syndrome -- an inherited form of mental reta

View all News

Stem Cells Index
Personalized Medicine Index

Today the Index Value closed at $2.39, down -0.02 -- a loss of -0.83%.

The index value dropped to 0.6566 from 0.6621 with an associated index market cap of $1.959 Billion.

Company	Ticker	Last	Change	%
Advanced Cell Technology	ACTC.OB	$0.39	-$0.02	-4.88%
Aastrom Biosciences	ASTM	$1.30	$0.02	1.56%
AVI Biopharma	AVII	$2.80	-$0.05	-1.75%
BrainStorm Cell Therapeutics	BCLI.OB	$1.00	-$0.05	-4.76%
CRYO-CELL International	CCEL.OB	$1.56	$0.01	0.65%
Cytori Therapeutics	CYTX	$6.11	-$0.17	-2.71%
Geron Corporation	GERN	$7.10	-$0.039	-0.55%
ThermoGenesis	KOOL	$2.52	$0.03	1.20%
MultiCell Technologies	MCET.OB	$0.05	-$0.008	-13.33%
NeoStem, Inc.	NEOI.OB	$0.51	-$0.01	-1.92%
Opexa Therapeutics Inc.	OPXA	$4.90	$0.03	0.62%
Osiris Therapeutics, Inc.	OSIR	$12.82	-$0.13	-1.00%
Ortec International, Inc.	OTCI.OB	$0.00	$0.00	0
Stem Cell Thera	SSS.V	$0.40	$0.03	8.11%
StemCells	STEM	$2.25	-$0.03	-1.32%
ViaCell	VIAC	$5.12	-$0.15	-2.85%

Last Close: Jul 25, 2007 17:15:01 PDT

Today the Index Value closed at $52.50, up 0.44 -- a gain of 0.85%.

The index value climbed to 14.4231 from 14.3022 with an associated index market cap of $343.649 Billion.

Company	Ticker	Last	Change	%
Abbott Laboratories	ABT	$52.30	-$0.21	-0.40%
Affymetrix, Inc.	AFFX	$24.86	$0.51	2.09%
Amgen, Inc.	AMGN	$57.16	$0.72	1.28%
Bayer AG	BAY	$72.94	-$0.69	-0.94%
<Becton, Dickinson and Company	BDX	$75.80	$1.32	1.77%
Beckman Coulter Inc	BEC	$73.28	$5.54	8.18%
Bio-Rad	BIO	$78.29	$0.01	0.01%
Ciphergen Biosystem	CIPH	$0.99	$0.01	1.02%
Dade Behring Hldgs Inc	DADE	$74.26	$18.35	32.82%
Quest Diagnostics	DGX	$56.02	-$0.40	-0.71%
Genentech	DNA	$75.81	$0.51	0.68%
dnaprint genomics, Inc.	DNAG.OB	$0.01	$0.0004	5.88%
Epix Pharmaceuticals, Inc.	EPIX	$4.70	-$0.20	-4.08%
Genomic Health, Inc.	GHDX	$19.76	$0.16	0.82%
Gene Logic	GLGC	$1.32	$0.02	1.54%
Invitrogen Corporation	IVGN	$75.19	$0.30	0.40%
Luminex Corporation	LMNX	$14.26	$0.74	5.47%
Monogram Biosciences, Inc.	MGRM	$1.72	$0.01	0.58%
Millipore	MIL	$80.39	$1.01	1.27%
Millenium Pharmaceuticals Inc.	MLNM	$10.55	$0.20	1.93%
Nanogen, Inc.	NGEN	$1.57	-$0.05	-3.09%
OSI Pharmaceuticals	OSIP	$33.00	-$0.16	-0.48%
Sequenom, Inc.	SQNM	$5.10	$0.04	0.79%
TM Bioscience	TMC.TO	$0.00	$0.00	0
Ventana Medical Systems, Inc.	VMSI	$83.99	$1.25	1.51%